Nicardipine Hydrochloride Injection
Product Images NDC 42571-394

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Nicardipine Hydrochloride (NDC 42571-394). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicardipine-crtn.jpg (Nicardipine Crtn)

FDA Label Image

Nicardipine-lbl.jpg (Nicardipine Lbl)

Nicardipine-lbl.jpg (Nicardipine Lbl)
This is a description of a medication called nicardipine hydrochloride. It is an injectable solution with a concentration of 25 mg/10 mL (2.5 mg/mL). The medication must be diluted before infusion and is intended for intravenous use only. The package contains a single-dose vial of 10 mL. Each vial contains 25 mg of nicardipine hydrochloride, along with benzoic acid, sodium chloride, and water for injection. The pH of the solution may have been adjusted using sodium hydroxide. The medication should be protected from light and stored at a temperature between 20°C and 25°C (68°F to 77°F). The usual dosage information can be found in the package insert. It is important to note that the FDA approved acceptance criteria for pH may differ from the USP. The medication is manufactured by Micro Labs USA, Inc. in Somerset, NJ, and the artwork code indicates that it was made in India.*
FDA Label Image

Structure (Nicardipine Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.